BioSpace News Archive

Adicet Bio, Inc., a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, announced Blake Aftab, Ph.D., has been promoted to the position of Senior Vice President and Chief Scientific Officer.

Neuronetics, Inc., a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, provided preliminary revenue results for the third quarter of 2021.

Fluidigm Corporation today announced a new co-marketing program to offer Visiopharm® image analysis software for faster and more streamlined analysis of data acquired through Imaging Mass Cytometry™ (IMC™).

ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced the execution of a joint venture agreement with Lucidam, a private investment firm based in Tokyo.

Medolife Rx, Inc. announced results from a study on its patented polarization methodology that compared the effectiveness of generic ibuprofen, a well-known pain relief drug that works by lowering inflammation by inhibiting the cyclooxygenase-2 enzyme’s activity in the body, versus polarized ibuprofen in inhibition of COX-2 activity in humans.

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the Chinese Health Authority has renewed Sensus’ license to market the SRT-100™ system in Greater China for an additional five years.

Jadeite Medicines Inc. entered into an exclusive licensing agreement with Albireo Pharma, Inc. for the development and commercialization of odevixibat in Japan for progressive familial intrahepatic cholestasis, Alagille syndrome and biliary atresia.

Sen-Jam Pharmaceutical has identified novel combinations of proven, safe drug molecules to address COVID-induced inflammation

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company’s Chief Financial Officer (CFO)

Everbridge , Inc. today announced its partnership with the COP26 World Climate Summit to present on the contributions of national early public warning solutions and critical event management (CEM) technology to unlocking resilience as a climate adaptation measure.